Nikolai Kley

Nikolai Kley was the founder of Forma Therapeutics, Inc. (2008, VP-Biology & Head-Drug Discovery Research) and Orionis Biosciences, Inc. (2015, President, Chief Executive Officer & Director).
Current jobs include Managing Director & Director at Orionis Biosciences BV (2020) and Professor at Princeton University.
Former jobs include Principal at Bristol Myers Squibb Co., Vice President at GPC Biotech AG, Fellow at The General Hospital Corp., Vice President at Genome Therapeutics Corp., and Fellow at Harvard Medical School.
Education includes an undergraduate degree from the University of Leeds, a doctorate from Max-Planck-Institute for Molecular Genetics, and a doctorate from Ludwig-Maximilians-Universität München.